Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitisRyan E. Feaver(HemoShear (United States)), Ajit Dash(HemoShear (United States))JCI InsightDecember 7, 201610.1172/jci.insight.90954Cited by 146SaveCiteExport RISWatch citationsRelated PapersThe Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug‐Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative|Drug Safety|2025|2